Adeno-associated virus (AAV) serotype 9 provides global cardiac gene transfer superior to AAV1, AAV6, AAV7, and AAV8 in the mouse and rat

Human Gene Therapy

Volumn 19, Issue 12, 2008, Pages 1359-1368

  Bish, Lawrence T ^a,d   Morine, Kevin ^a   Sleeper, Meg M ^b   Sanmiguel, Julio ^a   Wu, Di ^a   Gao, Guangping ^c   Wilson, James M ^a   Sweeney, H Lee ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

^c UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^d B400 Richards Building ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5 BROMO 4 CHLORO 3 INDOYL BETA DEXTRO GALACTOPYRANOSIDE; BETA ACTIN; BETA GALACTOSIDASE; PARVOVIRUS VECTOR; PARVOVIRUS VECTOR 1 CB LACZ; PARVOVIRUS VECTOR 6 CB LACZ; PARVOVIRUS VECTOR 7 CB LACZ; PARVOVIRUS VECTOR 8 CB LACZ; PARVOVIRUS VECTOR 9 CB LACZ; UNCLASSIFIED DRUG;

ADENO ASSOCIATED VIRUS; ADENO ASSOCIATED VIRUS 9; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHEMOLUMINESCENCE; CYTOMEGALOVIRUS; DOSE RESPONSE; ENZYME ACTIVITY; GENE; GENE EXPRESSION; GENE THERAPY; GENE TRANSFER; HEART DISEASE; HEART FUNCTION; HISTOCHEMISTRY; HUMAN; HUMAN CELL; LACZ GENE; MOUSE; NEWBORN; NONHUMAN; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RAT; SEROTYPE; TISSUE SPECIFICITY; TRANSGENIC MOUSE; VIRUS GENOME;

ANIMALS; ANIMALS, NEWBORN; BETA-GALACTOSIDASE; DEPENDOVIRUS; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; MICE; MYOCARDIUM; RATS; SPECIES SPECIFICITY;

ADENO-ASSOCIATED VIRUS; CYTOMEGALOVIRUS; MUS; MUS MUSCULUS; RATTUS; RODENTIA;

EID: 57749169283     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/hum.2008.123     Document Type: Article

References (31)

1. Andino, L.M., Conlon, T.J., Porvasnik, S.L., Boye, S.L., Hauswirth, W.W., and Lewin, A.S. (2007). Rapid, widespread transduction of the murine myocardium using self-complementary adeno-associated virus. Genet. Vaccines Ther. 5, 13.
2. Andino, L.M., Takeda, M., Kasahara, H., Jakymiw, A., Byrne, B.J., and Lewin, A.S. (2008). AAV-mediated knockdown of phospholamban leads to improved contractility and calcium handling in cardiomyocytes. J. Gene Med. 10, 132-142.
3. Arruda, V.R., Stedman, H.H., Nichols, T.C., Haskins, M.E., Nicholson, M., Herzog, R.W., Couto, L.B., and High, K.A. (2005). Regional intravascular delivery of AAV-2-F.IX to skeletal muscle achieves long-term correction of hemophilia B in a large animal model. Blood 105, 3458-3464.
4. Bostick, B., Ghosh, A., Yue, Y., Long, C., and Duan, D. (2007). Systemic AAV-9 transduction in mice is influenced by animal age but not by the route of administration. Gene Ther. 14, 1605-1609.
5. Carter, B.J. (2004). Adeno-associated virus and the development of adeno-associated virus vectors: A historical perspective. Mol. Ther. 10, 981-989.
6. Choi, V.W., Samulski, R.J., and McCarty, D.M. (2005). Effects of adeno-associated virus DNA hairpin structure on recombination. J. Virol. 79, 6801-6807.
7. Du, L., Kido, M., Lee, D.V., Rabinowitz, J.E., Samulski, R.J., Jamieson, S.W., Weitzman, M.D., and Thistlethwaite, P.A. (2004). Differential myocardial gene delivery by recombinant serotype-specific adeno-associated viral vectors. Mol. Ther. 10, 604-608.
8. Gao, G., Vandenberghe, L.H., Alvira, M.R., Lu, Y., Calcedo, R., Zhou, X., and Wilson, J.M. (2004). Clades of adeno-associated viruses are widely disseminated in human tissues. J. Virol. 78, 6381-6388.
9. Gao, G.P., Alvira, M.R., Wang, L., Calcedo, R., Johnston, J., and Wilson, J.M. (2002). Novel adeno-associated viruses from rhesus monkeys as vectors for human gene therapy. Proc. Natl. Acad. Sci. U.S.A. 99, 11854-11859.
10. Godecke, A. (2006). AAV vector re-targeting: A small step on the way to cardiac-specific gene transfer. Cardiovasc. Res. 70, 6-8.
11. Hajjar, R.J., Zsebo, K., Deckelbaum, L., Thompson, C., Rudy, J., Yaroshinsky, A., Ly, H., Kawase, Y., Wagner, K., Borow, K., Jaski, B., London, B., Greenberg, B., Pauly, D.F., Patten, R., Starling, R., Mancini, D., and Jessup, M. (2008). Design of a phase 1/2 trial of intracoronary administration of AAV1/SERCA2a in patients with heart failure. J. Card. Fail. 14, 355-367.
12. Hildinger, M., Auricchio, A., Gao, G., Wang, L., Chirmule, N., and Wilson, J.M. (2001). Hybrid vectors based on adeno-associated virus serotypes 2 and 5 for muscle-directed gene transfer. J. Virol. 75, 6199-6203.
13. Inagaki, K., Fuess, S., Storm, T.A., Gibson, G.A., McTiernan, C.F., Kay, M.A., and Nakai, H. (2006). Robust systemic transduction with AAV9 vectors in mice: Efficient global cardiac gene transfer superior to that of AAV8. Mol. Ther. 14, 45-53.
14. Kawamoto, S., Shi, Q., Nitta, Y., Miyazaki, J., and Allen, M.D. (2005). Widespread and early myocardial gene expression by adeno-associated virus vector type 6 with a β-actin hybrid promoter. Mol. Ther. 11, 980-985.
15. McCarty, D.M., Monahan, P.E., and Samulski, R.J. (2001). Self-complementary recombinant adeno-associated virus (scAAV) vectors promote efficient transduction independently of DNA synthesis. Gene Ther. 8, 1248-1254.
16. McCarty, D.M., Fu, H., Monahan, P.E., Toulson, C.E., Naik, P., and Samulski, R.J. (2003). Adeno-associated virus terminal repeat (TR) mutant generates self-complementary vectors to overcome the rate-limiting step to transduction in vivo. Gene Ther. 10, 2112-2118.
17. Miyagi, N., Rao, V.P., Ricci, D., Du, Z., Byrne, G.W., Bailey, K.R., Nakai, H., Russell, S.J., and McGregor, C.G. (2008). Efficient and durable gene transfer to transplanted heart using adeno-associated virus 9 vector. J. Heart Lung Transplant 27, 554-560.
18. Muller, O.J., Leuchs, B., Pleger, S.T., Grimm, D., Franz, W.M., Katus, H.A., and Kleinschmidt, J.A. (2006). Improved cardiac gene transfer by transcriptional and transductional targeting of adeno-associated viral vectors. Cardiovasc. Res. 70, 70-78.
19. Muller, O.J., Katus, H.A., and Bekeredjian, R. (2007). Targeting the heart with gene therapy-optimized gene delivery methods. Cardiovasc. Res. 73, 453-462.
20. Pacak, C.A., Mah, C.S., Thattaliyath, B.D., Conlon, T.J., Lewis, M.A., Cloutier, D.E., Zolotukhin, I., Tarantal, A.F., and Byrne, B.J. (2006). Recombinant adeno-associated virus serotype 9 leads to preferential cardiac transduction in vivo. Circ. Res. 99, e3-e9.
21. Palomeque, J., Chemaly, E.R., Colosi, P., Wellman, J.A., Zhou, S., Del Monte, F., and Hajjar, R.J. (2007). Efficiency of eight different AAV serotypes in transducing rat myocardium in vivo. Gene Ther. 14, 989-997.
22. Pleger, S.T., Most, P., Boucher, M., Soltys, S., Chuprun, J.K., Pleger, W., Gao, E., Dasgupta, A., Rengo, G., Remppis, A., Katus, H.A., Eckhart, A.D., Rabinowitz, J.E., and Koch, W.J. (2007). Stable myocardial-specific AAV6-S100A1 gene therapy results in chronic functional heart failure rescue. Circulation 115, 2506-2515.
23. Sakata, S., Lebeche, D., Sakata, N., Sakata, Y., Chemaly, E.R., Liang, L.F., Tsuji, T., Takewa, Y., Del Monte, F., Peluso, R., Zsebo, K., Jeong, D., Park, W.J., Kawase, Y., and Hajjar, R.J. (2007). Restoration of mechanical and energetic function in failing aortic-banded rat hearts by gene transfer of calcium cycling proteins. J. Mol. Cell Cardiol. 42, 852-861.
24. Schirmer, J.M., Miyagi, N., Rao, V.P., Ricci, D., Federspiel, M.J., Kotin, R.M., Russell, S.J., and McGregor, C.G. (2007). Recombinant adeno-associated virus vector for gene transfer to the transplanted rat heart. Transpl. Int. 20, 550-557.
25. Sipo, I., Fechner, H., Pinkert, S., Suckau, L., Wang, X., Weger, S., and Poller, W. (2007). Differential internalization and nuclear uncoating of self-complementary adeno-associated virus pseudotype vectors as determinants of cardiac cell transduction. Gene Ther. 14, 1319-1329.
26. Vandendriessche, T., Thorrez, L., Acosta-Sanchez, A., Petrus, I., Wang, L., Ma, L., L, De Waele, L., Iwasaki, Y., Gillijns, V., Wilson, J.M., Collen, D., and Chuah, M.K. (2007). Efficacy and safety of adeno-associated viral vectors based on serotype 8 and 9 vs. lentiviral vectors for hemophilia B gene therapy. J. Thromb. Haemost. 5, 16-24.
27. Woo, Y.J., Zhang, J.C., Taylor, M.D., Cohen, J.E., Hsu, V.M., and Sweeney, H.L. (2005). One year transgene expression with adeno-associated virus cardiac gene transfer. Int. J. Cardiol. 100, 421-426.
28. Wright, M.J., Wightman, L.M., Lilley, C., De Alwis, M., Hart, S.L., Miller, A., Coffin, R.S., Thrasher, A., Latchman, D.S., and Marber, M.S. (2001). In vivo myocardial gene transfer: Optimization, evaluation and direct comparison of gene transfer vectors. Basic Res. Cardiol. 96, 227-236.
29. Yue, Y., Li, Z., Harper, S.Q., Davisson, R.L., Chamberlain, J.S., and Duan, D. (2003). Microdystrophin gene therapy of cardiomyopathy restores dystrophin-glycoprotein complex and improves sarcolemma integrity in the mdx mouse heart. Circulation 108, 1626-1632.
30. Zhang, J.C., Woo, Y.J., Chen, J.A., Swain, J.L., and Sweeney, H.L. (1999). Efficient transmural cardiac gene transfer by intrapericardial injection in neonatal mice. J. Mol. Cell. Cardiol. 31, 721-732.
31. Zincarelli, C., Soltys, S., Rengo, G., and Rabinowitz, J.E. (2008). Analysis of AAV serotypes 1-9 mediated gene expression and tropism in mice after systemic injection. Mol. Ther. 16, 1073-1080.